Top Tech Companies (1,867)
Don't see your company?
Create a company profile
ZOE is a nutritional science start-up on a mission to help people eat with confidence. Our name means “life” and we’re committed to helping people live it to their fullest by harnessing the power of scientific research, software engineering and artificial intelligence Our team tackles a range of complex product, engineering, data, logistics, UI/UX challenges that enable our customers to understand their unique biological response to food We are builders and lifelong learners - connected by a common desire to leverage our talent for helping the world Since our launch in 2017, we grew our team from 5 to 120 extraordinary individuals. Our products, insights and advise has been covered by many household media brands and we're only just beginning. We're currently hiring and we'd love to hear from you - https://joinzoe.com/careers
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity. The company is leveraging the Rhythm Engine -- comprised of its TEMPO Registry, GO-ID genotyping study and Uncovering Rare Obesity program -- to improve the understanding, diagnosis and potentially the treatment of these disorders. For healthcare professionals, visit www.RareObesity.com for more information. For patients and caregivers, visit www.LEADforRareObesity.com for more information.
.png)
Outcomes4Me is an AI-driven patient empowerment platform that helps cancer patients navigate their care and gain access to personalized treatment options. The company is on a mission to democratize healthcare by providing real-time, evidence-based clinical information to cancer patients, ensuring they can take a more active role in their own care. At the same time, Outcomes4Me is working to promote health equity by generating deeper insights that improve care, accelerate research, and lead to better outcomes. Based in Boston, Massachusetts, Outcomes4Me is a woman-led company of seasoned healthcare, oncology, pharmaceutical, consumer, and technology veterans.
Karen Clark & Company develops software that provides innovative tools for catastrophe risk management. Over two decades ago, Nobel Peace Prize Honoree Karen Clark pioneered the catastrophe risk modeling techniques and solutions used today by virtually every insurance and reinsurance company in the world. Karen Clark & Company is now leading the next generation of catastrophe risk management solutions to address the evolving needs of its clients. RiskInsight®, the first open loss modeling platform, is used by insurance and reinsurance companies in US and non-US markets and supports new catastrophe models for major perils such as hurricanes, earthquakes, and severe convective storms. Additional innovations by Karen Clark & Company include the Characteristic Event (CE) methodology and real-time event tracking.
We are an award-winning marketing services firm that merges storytelling and technology to bring health, wealth, and happiness to the world. Here, the potential is limitless. People come to MERGE looking for a new way; for ideas and solutions that will make an impact. Our name reflects our belief that collaboration across disciplines leads to better results. With offices in Chicago, Boston, Atlanta, New York City, Costa Mesa, Kansas City, and Denver, we continuously seek and make new connections through creative and technology. We’re here for the strivers; those who are ambitious and want to emerge to the top.
We created the world’s first handheld, whole-body ultrasound probe: the Butterfly iQ. This innovative device reduces the cost of the traditional ultrasound system by miniaturizing it onto a single semiconductor silicon chip with our patented Ultrasound-on-Chip™ technology. We’ve paired our handheld probe with cloud-based software to create a true imaging solution—one that delivers vital information, in a variety of use cases, across multiple care settings. This information supports timely clinical decision-making and creates workflow improvements that help clinicians achieve better outcomes for the people in their care. Our Butterfly iQ and next-generation Butterfly iQ+ have received CE Mark and FDA clearance, and are being sold in hospitals and clinics in 20 countries around the world. In 2021, Butterfly began trading publicly on the NYSE. By joining Butterfly Network, you will be helping to transform the future of healthcare. Our team helps us maximize global impact, motivated by the idea that our products will impact the lives of millions, including the people they love.
Inspire Brands was founded in February 2018 with a vision to invigorate great brands and supercharge their long-term growth. In an industry facing increasing disruption, our leaders saw an opportunity to build a restaurant company unlike any other – one that brings together differentiated yet complementary brands and aims to make them stronger than they would be on their own. Found inherently in the purposes of our family of brands, we identified a common thread between our restaurants – the capacity to inspire. From guest experience to career development to community well-being, Inspire plays a role in the lives of millions of people every day.
What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Our goal is to discover, develop, manufacture, and commercialize transformative medicines for a range of serious diseases, including eye diseases, blood diseases, and cancer. We are a vibrant company full of hope, possibilities, and a belief that, working together as One Editas, we can truly revolutionize the development of medicines. We are on an important journey to unlock the full potential of genome editing technology. A journey fueled by our distinct culture, expert team of Editas Medicine ‘Editors’, and the patients we aspire to help around the world. Connect with us to hear about the tremendous progress and scientific advancements we’ve already made and the next breakthrough on the horizon. If you are ingenious, passionate and resilient, come join the revolution. Repairing broken genes is only the beginning.
Security Innovation is an authority on software security and helps organizations build and deploy more secure software. Global technology vendors and enterprise IT organizations such as Microsoft, IBM, FedEx, ING, Symantec, Coca-Cola and GE rely on our expertise to understand the security risks in their software systems and facilitate the software and process change necessary to mitigate them. Security Innovation specializes in software security, an area where traditional “information security” and “business” consultants tend to struggle. We have been analyzing application vulnerabilities and risk for almost a decade and were one of the first providers of software risk solutions to Fortune 500 firms. Our unrivaled proficiency in technical analysis, coupled with sound knowledge of business processes, results in world-class solutions that bridge the gap between application security holes and risk management optimization.
PRECISIONeffect is the only advertising & marketing agency devoted to working with healthcare companies who are changing the standard of care. The status quo is the blank canvas we use to redefine how we help our clients change the standard of care. Using an evidence-based, data-driven approach, we can bring the best breed of experts to the table from clinical drug development, econ policy, and payer to aid in brand decisions. For an emerging biotech or pharmaceutical company, we can provide you with a full service partnership that is seamless.
.jpeg)
.jpg)
.jpg)
Founded in 1985, Institutional Shareholder Services group of companies (ISS) empowers investors and companies to build for long-term and sustainable growth by providing high-quality data, analytics and insight. ISS, which is majority owned by Deutsche Bourse Group, along with Genstar Capital and ISS management, is a leading provider of corporate governance and responsible investment solutions, market intelligence, fund services, and events and editorial content for institutional investors and corporations, globally. ISS’ 2,200 employees operate worldwide across 29 global locations in 15 countries. It’s approximately 3,100 clients include many of the world’s leading institutional investors who rely on ISS’ objective and impartial offerings, as well as public companies focused on ESG and governance risk mitigation as a shareholder value enhancing measure. Clients rely on ISS’ expertise to help them make informed investment decisions.
FOLX Health is the first digital healthcare service provider designed by and for the medical needs of the LGBTQIA+ community.
Ryan is a tax services firm providing tax advisory and consulting services on a multi-jurisdictional basis. Ryan, an award-winning global tax services and software provider, is the largest Firm in the world dedicated exclusively to business taxes. With global headquarters in Dallas, Texas, the Firm provides an integrated suite of federal, state, local, and international tax services on a multijurisdictional basis, including tax recovery, consulting, advocacy, compliance, and technology services. Ryan is a seven-time recipient of the International Service Excellence Award from the Customer Service Institute of America (CSIA) for its commitment to world-class client service. Empowered by the dynamic myRyan work environment, which is widely recognized as the most innovative in the tax services industry, Ryan’s multidisciplinary team of more than 2,500 professionals and associates serves over 14,000 clients in more than 50 countries, including many of the world’s most prominent Global 5000 companies.
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged or poorly drugged proteins to create new ways to fight cancer. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years
Proof℠ is the world's first identity-assured transaction management platform. Developed by the same market leaders and experts who brought notarization online with Notarize℠, Proof offers trust in a digital world by verifying identities and securing transactions to protect your business and its customers. When risk is low and speed matters, get it signed. When the law dictates it, get it notarized. When trust matters, you need Proof.
MUFG (Mitsubishi UFJ Financial Group) is one of the world's leading financial groups. Headquartered in Tokyo and with over 360 years of history, MUFG has a global network with over 2,500 locations in more than 50 markets including the Americas, Europe, the Middle East and Africa, Asia and Oceania. The Group has over 170,000 employees and offers services including commercial banking, trust banking, securities, credit cards, consumer finance, asset management, and leasing. Through close partnerships among our group companies, the Group aims to be the world's most trusted financial group, flexibly responding to all of the financial needs of its customers, serving society, and fostering shared and sustainable growth for a better world. MUFG's shares trade on the Tokyo, Nagoya, and New York stock exchanges.
At WinnCompanies, we turn housing into homes. As a leader in property development and management, we’re creating a challenging, fast-paced workplace where teamwork, innovation and mutual respect are both valued and rewarded. We believe the relationships we build with each other are just as important as the work we do. Explore your passion within one of our three business units – WinnDevelopment, WinnResidential and WinnMilitary. Operations, sales, compliance, maintenance, marketing, IT, HR, accounting and finance. No matter your expertise, your work will impact people who are more than just residents to us. They’re individuals, families and heroes. Founded in 1971, we are committed to enhancing the lives of our communities. We fund college scholarships for residents; host community service and volunteer activities and more. Come join our 3,800 team members in making a difference in your local community. With more than 600 sites in 23 states and D.C., there’s a place here for you to grow your career.
Kytopen, an MIT spin-out, is a transformative biotechnology company that offers a customizable yet scalable multi-solution platform, which seamlessly links the discovery, development and manufacturing phases of cell engineering. Flowfect®, a gentle, non-viral delivery method unlocks new therapeutic approaches, by engineering immune cells with minimal disruption, preserving the functionality and viability of human cells and enhancing the cell’s biology. The Flowfect® platform accelerates therapies from the bench to clinical through flexibility and scalability, which drives higher cell yields, faster approvals, and better outcomes from potentially curative cell-based treatments. Kytopen’s goal is to enable simple and efficient non-viral manufacturing of cell therapies in days versus weeks to increase access to many more patients. For more information, visit: www.kytopen.com
At PathAI our mission is to improve patient outcomes with AI-powered technology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning.
Hopper is the smart way to book travel on your phone. Combining massive amounts of data and advanced machine learning algorithms, Hopper predicts and analyzes airfare and accommodation to save users money and enable them to travel more often.
